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Autonomicandperipheralneuropathiesarewell-describedcomplicationsindiabetes.Diabetesmellitusisalsoassociatedtocentral
nervoussystemdamage.Thislittle-knowncomplicationischaracterizedbyimpairmentofbrainfunctionsandelectrophysiological
changes associated with neurochemical and structural abnormalities. The purpose of this study was to investigate brain structural
and ultrastructural changes in rats with streptozotocin-induced diabetes. Cerebral cortex, hypothalamus, and cerebellum were
obtained from controls and 8 weeks diabetic rats. Light and electron microscope studies showed degenerative changes of
neurons and glia, perivascular and mitochondrial swelling, disarrangement of myelin sheath, increased area of myelinated axons,
presynaptic vesicle dispersion in swollen axonal boutoms, fragmentation of neuroﬁlaments, and oligodendrocyte abnormalities.
In addition, depressive mood was observed in diabetic animals. The brain morphological alterations observed in diabetic animals
could be related to brain pathologic process leading to abnormal function, cellular death, and depressive behavioral.
Copyright © 2009 Juan P. Hern´ andez-Fonseca et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Besides autonomic and peripheral neuropathy, diabetes is
also associated with gradually developing end-organ damage
in the central nervous system [1]. This complication is
referred as “diabetic encephalopathy” and characterized by
impairment of cognitive functions and electrophysiological
changes [2]. These functional changes are accompanied by
structural and neurochemical abnormalities as well as by
degenerative changes in the brain that could be related to
chronically increased intracellular glucose concentration [3–
5]. Several brain regions have been studied by biochemical
and structural analysis in diabetes; however, few studies
have been performed to determine the ultrastructural fea-
tures of diabetes in cerebral cortex, hypothalamus, and
cerebellum. These regions are involved in cognitive, motor,
and neuroendocrine activities [6–9]; thus, their aﬀectations
during diabetes are relevant in the pathogenesis of the
disease. This study was aimed to characterize the structural
and ultrastructural brain changes in streptozotocin (STZ)
induced diabetic rats.
2. Methods
2.1. Streptozotocin-Induced Diabetes. Male Sprague-Dawley
rats weighing 100–150g (Instituto Venezolano de Investiga-
ciones Cientiﬁcas, IVIC) were used. Animals were housed,
and food and water were provided ad libitum. Diabetes
was induced by intravenous injection of streptozotocin
(55mg/kg in 0.2M sodium citrate, pH 4.0; Sigma-Aldrich,
St. Louis, MO, USA). Control rats (n = 10) were injected
with vehicle. Diabetes was veriﬁed at weeks 1, 6, and 8 by
measurement of tail blood glucose levels using a glucometer
(Lifescan, Milpitas, CA, USA). Rats having a blood glucose
level of ≥200mg/dL were considered to be diabetic (n = 8).2 Experimental Diabetes Research
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Figure 1: Grades of myelin alterations (I, II, and III). Arrows indicate local disarrangement of myelin sheath. Scale bars (a) and (b): 0.2μ;
(c): 1μ;( d ) :0 . 5μ;( e ) :2μ. There are uranyl acetate and lead citrate staining.
To prevent hypoglycemia, rats were allowed unlimited access
to water with 2% glucose during 3days after STZ injection.
Subsequently, rats were allowed unlimited access to tap
water. Urine glucose and ketoacids (assessed as acetoacetate)
were evaluated using Multistix urinalysis strips (Bayer;
Fisher Scientiﬁc, Germany). After 8weeks, control and
hyperglycemic rats were anesthetized by an intraperitoneal
injection of tiobarbituric, and brain was perfused by intrac-
ardiac via using a 0.9% of saline solution containing 4% of
glutaraldehyde. Thereafter, cerebrum and cerebellum were
obtained for microscopy studies. Experimental procedures
followed the ethical guidelines of the committee of bioethical
and biosecurity of FONACIT (Caracas, Venezuela) and the
committee of bioethical of Medical School (Universidad del
Zulia, Maracaibo, Venezuela).
2.2. Light and Electron Microscopy. Pieces of selected brain
regions (cerebral cortex, hypothalamus and cerebellum)
were immediately placed in 2.5% glutaraldehyde in 0.1M
cacodylate buﬀer, chopped to get pieces of approximately
1mm 2, and kept in the same glutaraldehyde solution for
12hours at room temperature. Samples were postﬁxed in
1% osmium tetroxide for 1.5hours, dehydrated in increasing
concentrations of alcohol, immersed in propylene oxide, and
embedded in Araldite 502 resin at 60
◦C. To conﬁrm that
h y p o t h a l a m i ca r e aa n da l ll a y e r so fc e r e b r a la n dc e r e b e l l a r
samples were analyzed, thick tissue sections were made,
stainedwithtoluidineblueandanalyzedbylightmicroscopy.
Ultrathin sections were placed on grids and stained with
uranylacetateandleadcitrate.Thethicksectionswereexam-
ined using a light microscope (Axioscop, Zeiss, Germany),
and quantitative analysis of myelinated axonal transversal
areas (cytoplasm areas) was performed using an IA32 system
software (LECO Corporation, MI, USA); the grids with
thin sections were examined in a transmission electron
microscope (JEOL 1010, Akishima, Japan).
2.3. Quantiﬁcation of Myelin and Mitochondrial Alterations.
Randomly selected myelinated axons (100 per each cerebral
cortex,hypothalamusorcerebellumareas)werecountedand
classiﬁed using an electron microscope. Abnormal myelin
wasarbitrarilydeﬁnedonthebasisofmyelindisarrangement
in type I: well-preserved myelin with local disarrangement
of myelin sheath, type II: diﬀused local disarrangement of
myelin sheath resembling a “collar” but preserving structural
arrangement, and type III: collapsed myelin to form ovoid,
diﬀused disarrangement, fusion or broken myelin sheath
(Figure 1). Mitochondrial alterations were studied in ran-
domlyselectedcellularbodyandneuropilareas(100pereach
area) using an electron microscope. These organelles were
countedandclassiﬁedasvacuolatedmitochondria(VM)and
swollen mitochondria (SM) (Figure 2).
2.4. Apoptosis. To determine apoptosis a histological assay
for selective labeling of cells with degraded DNA in tissue
sections was used [10]. Apoptosis was determined usingExperimental Diabetes Research 3
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Figure 2: Mitochondrial alterations in diabetes. (a) Normal (arrows) and swollen mitochondria (crossed arrows) in neuronal body.
(b) Vacuolated mitochondria in neuropil (arrows). There is intense mitochondrial swelling in neuropil (crossed arrow); note a normal
mitochondria (arrow). (d) Contribution of mitochondrial degeneration (crossed arrow) to myelin like formation (arrow head); note two
normal mitochondria (arrows). Bars in (a), (b), and (c) 0.2μ;( d ) :0 . 5μ. There are uranyl acetate and lead citrate staining.
a commercial kit following the manufacturer’s indications
(Promega, Madison, WI, USA). Areas of randomly selected
tissues were analyzed and results were expressed as number
of apoptotic nuclei per 0.065mm2 of area. Apoptotic mor-
phological features were also study by electron microscopy
procedures.
2.5. Forced Swimming Test (FST) and Motor Activity. This
test was performed with modiﬁcations of the Porsolt’s
procedure [11] to determine the struggling time in control
and diabetic rats. Brieﬂy, FST was performed as follows: 8-
week diabetic and control rats were placed individually in
glass cylindrical tanks containing water (25
◦C) at a depth
of 30cm. FST was performed daily for 15days, and the
struggling time was measured during 30-minute test. A
rat was judged to be immobile when it remained ﬂoating
in the water and made only small movements to keep
its head above water. Struggle occurred when the rats
were diving, jumping, strongly moving all four limbs, or
scratching the walls. Animals were tested for motor activity
in an optical digital animal activity monitor (Opto-Varimex-
Minor, Columbus Instruments Co., Columbus OH, USA),
which records motor activity values (pulses) automatically.
Prior to the FST, the animals were placed for 5 minutes
in the activity monitor where total horizontal activity and
ambulatory and stereotypic movements were obtained.
Table 1: Control and diabetes parameters.
Parameters Control (n = 10) Diabetes (n = 8)
Blood glucose (mg/dL) 127.5 ± 21.8 306.4 ± 84.66a
Weight gain (g) 287.9 ± 39.2 179.4 ± 82a
Urine glucose − +
Urine ketoacids −−
aP < .05 versus control.
2.6. Statistical Analysis. Data are expressed as mean ± SD.
Statistical signiﬁcance was determined by unpaired t-test
using Graph Pad InStat. Diﬀerences with P<. 05 values were
considered statistically signiﬁcant.
3. Results
3.1. Biochemical Parameters. STZ injection produced dia-
betic animals with consistent high levels of plasma glucose
(Week 1: 409.13 ± 92.55; Week 6: 363 ± 77.92; Week 8: 306.4
± 84.66mg/dL). Table 1 shows the biochemical parameters
at week 8 when animals were sacriﬁced. Increased plasma
glucose and urine glucose excretion were observed. At this
time urine ketoacids were not detected. Decreased weight
gain was observed in diabetic animal when compared to
controls.4 Experimental Diabetes Research
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Figure 3: Structural alterations in diabetes. (a) Normal cerebral pyramidal cells (arrows). (b) Vacuolization of pyramidal cells in diabetes
(arrows)andaprobablyapoptoticcell (crossedarrow).(c)Purkinjecells (arrows)in normalcerebellar section.(d)Vacuolization ofPurkinje
cells (arrows); note also vacuolization of granular layer cells. (e) Vacuolization of neuropil and cells (arrows) in cerebellar molecular layer. (f)
Vacuolization of dark cells (arrows) and neuropil in hypothalamus of diabetic rat. GL: granular layer; ML: molecular layer. Magniﬁcation:
×1000 (a)–(d); ×400 ((e) and (f)). There is toluidine blue staining.
3.2. Light Microscopy Analysis. Analysis of toluidine-stained
sections showed vacuolization of neurons, glia, as well as the
neuropil in cerebral cortex, hypothalamus, and cerebellum
of diabetic rats. Cellular vacuoles were mainly observed
in pyramidal cells, Purkinje cells, and cells of cerebellar
granulose and molecular layers. Cells with picnotic nuclei
and condensed cytoplasm suggesting apoptotic cells were
observed in normal and diabetic animals (Figure 3). Analysis
of transversal sections of myelinated axons showed increased
area in cerebral and cerebellar axons when compared to
normal (Figure 4).
3.3. Apoptosis. Presence of apoptosis in light microscopy
analysis was conﬁrmed by TUNEL assay and by electron
microscopy. Increased numbers of TUNEL positive cells
were observed in cerebral cortex and cerebellum in diabetic
animals when compared to controls, but they failed to reach
a statistical signiﬁcance. Electron microscopy study showed
cells with condensed chromatin and cytoplasm in the brain
parenchyma; some of these cells represent endothelial and
perivascular cells (Figure 5).
3.4. Ultrastructural Analysis. Cerebral cortex, hypothalamus,
and cerebellum showed ultrastructural features suggesting
general swelling of neurons, glia, and neuropil. Cellular
swelling was represented by local cytoplasm swelling, dilated
rough endothelial reticulum (RER) fragments and swollen
organelles mainly mitochondria, or by total cellular swelling
(Figures 6, 7,a n d8).
Vascular alterations were represented by endothelial cells
showing local swelling areas or intense cellular swelling.
In some instance, endothelial cell apoptosis was observed
(Figure 9). Frequently, intense swelling of perivascular cells
was observed in several blood vessels (Figure 9).Experimental Diabetes Research 5
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Figure 4: Area of mielinated axons in diabetes. (a) Axonal area of myelinated axons. (b) Normal cerebellar area (white substance) showing
myelinated axons. (c) Diabetic cerebellar area (white substance) showing myelinated axons. Magniﬁcation: ×400 ((b) and (c)). There is
toluidine blue staining.
Mitochondrial abnormalities were observed in both
cellular body and neuropil in the diﬀerent regions. Increased
vacuolated and swollen mitochondria in cerebral cortex,
hypothalamusandcerebellumwereobservedindiabeticrats.
No signiﬁcant diﬀerences were observed when mitochon-
drial abnormalities in cellular body were compared with
those in neuropil of diabetic animals. (Table 2 and Figure 2).
Preserved mitochondria were frequently found besides
altered mitochondria and, in some instance, myelin-like
formations from degenerated mitochondria were observed
(Figure 2).
Axonal abnormalities were found in STZ-animals. Dia-
betic animals showed an elevated number of myelin alter-
ations. Arbitrarily myelin alterations were classiﬁed as types
I, II, and III according to the grade of myelin disarrangement
(Figure 1). In general a low percentage of myelin alterations
were observed in normal tissues. Tendency to increased
myelin alterations was observed in cerebral cortex in dia-
betic rats, but only alteration of type III was statistically
signiﬁcant (Table 3). Elevated percentage of total types I,
II, and III myelin alterations were observed in cerebellum
and hypothalamus from diabetic animals (Table 3). Altered
oligodendrocytes with local cytoplasm swelling, swollen
organelles, and myelinated axons showing diﬀerent types of
myelin alterations were observed (Figure 10). Several both
myelinated and unmyelinated axons showed fragmentation
of neuroﬁlaments (Figure 11). Synaptic boutons showed
diﬀerent grades of swelling with swollen mitochondria and
dispersion of presynaptic vesicles (Figure 12).
3.5. FST and Motor Activity. Diabetic rats showed depressive
status. As shown in Table 4 diabetic animals had decreased
struggle activity compared to controls when they were
subjected to FST. Motor activity was also decreased in
diabetes as observed in the lower number of movements and
diminished ambulatory activity in diabetic animals.
4. Discussion
Diabetic encephalopathy, characterized by impaired cogni-
tive functions and neurochemical and structural abnormali-
ties, may involve direct neuronal damage. This study assesses
the eﬀect of 8-week diabetic condition on the structure
and ultrastructure of relevant regions of the rat brain. In
general, all regions in this study presented morphologic
alterations suggesting swelling of the brain. Increased area
of myelinated axons in cerebral cortex and cerebellum6 Experimental Diabetes Research
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Figure 5: Apoptosis in central nervous system of normal and diabetic rat. (a) TUNEL positive cells: A: Cerebral molecular-granulose zone.
B:Cerebralpyramidalzone.C:Choroidsplexus.D:Cerebellargranulosezone.E:Cerebellarmolecularzone.(b)Apoptoticcellincerebellum
(arrow). (c) Perivascular apoptotic cell in cerebellum (arrow). Short arrow indicates capillary. Scale bars are 1μ. There are uranyl acetate and
lead citrate staining.
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Figure 6: Normal and diabetic cerebellum. (a) Normal granulose zone; Bar: 2μ. (b) Diabetic granulose zone showing cell (arrow) with
swollen mitochondria. Asterisk indicates swollen neuropil; Bar: 1μ. There are uranyl acetate and lead citrate staining.Experimental Diabetes Research 7
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Figure 7: Normal and diabetic cerebral cortex. (a) Normal cerebral area. Arrow indicates capillary; Bar: 2μ. (b) Diabetic cerebral zone
showing swollen neuropil; Bar: 1μ. (c) Dark cell showing diﬀerent grades of mitochondrial swelling (arrows); Bar: 0.5μ; N: nucleus. There
are uranyl acetate and lead citrate staining.
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Figure 8: Normal and diabetic hypothalamus. (a) Normal hypothalamus area; Bar: 2μ; (b) Diabetic hypothalamus area showing a swollen
(asterisk) and normal (double asterisk) neuropil areas. Arrow indicates swollen cell; N: nucleus; Bars: 1μ; There are uranyl acetate and lead
citrate staining.
and diverse degree of neuronal body swelling address this
observation.Inthisregard,brainedemaisthemostcommon
serious complication of diabetic ketoacidosis in children,
where mechanisms of rapid changes in serum osmolality
during therapy and others such as brain ischemia have been
suggested [12–15]. In these experiments, diabetic rats were
not in ketoacidosis, and since they did not receive insulin,
hyperglycemia could induce brain damage. Thus, hyper-
glycemia may cause brain acidosis and dehydration, both
involved in diminished cerebral blood ﬂow and ischemia
[16–18]. Ischemia-related edema involves stimulation of
brain Na-K-Cl cotransporter system facilitating edema for-
mation and swelling of endothelial cells [19–24]. Thus, it
is possible that those mechanisms contribute to the brain
edema observed in this study; however, since lack of insulin
may have consequences in terms of neuronal function,
we cannot discard others inducers of brain alterations in
diabetes. The ultrastructural lesions observed in this study
are not considered to be a consequence of STZ, since a toxic
eﬀect of this compound on the central nervous system has
been excluded [25].
Endothelial and perivascular edema observed in diabetic
rats could induce an altered blood-brain barrier (BBB)
function.Studiesonanimalmodelshaveshownthatdiabetes
has deleterious eﬀects on the BBB which may contribute
to neurological complications associated to this condition
[26]. Since perivascular pericytes, astrocytes, and adipocytes
play an important role maintaining the function of the BBB
[27, 28], perivascular swelling observed in diabetic rats could
represent swollen pericytes, astrocytes, or adipocytes leading
to disruption of the BBB functions.
Mitochondrial alterations were observed as other rele-
vant ﬁnding in diabetic rats. An arbitrary classiﬁcation of
vacuolated mitochondria and swollen mitochondria in order
to suggest diﬀerent degrees of mitochondrial lesion was used
in this study.In general,thepercentageofmitochondria with
vacuoles preserving the mitochondrial structure was higher
than swollen mitochondria, suggesting progressive mito-
chondrial damage. Mitochondrial structural alterations have
been related to oxidative stress. Previous reports have shown
swelling of mitochondria during oxidative and nitrosative
stress in diabetic STZ-rats [3, 29, 30]; this alteration was8 Experimental Diabetes Research
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Figure 9: Central nervous system blood vessels in diabetes. (a) and (b) Diverse grades of endothelial cytoplasm swelling (arrows); bars:
0.5μ. (c) Swelling of perivascular cell (arrow); E: endothelial cell; asterisk: vascular lumen; bar: 1μ. (d) Intense perivascular swelling (arrows)
preserving endothelium; bar: 2μ. (e) Intense perivascular swelling (asterisks) with apoptosis of endothelial cell (arrow); bar: 1μ. (f) Intense
neuropil swelling (arrow) besides well-preserved blood vessels; P: pericyte; E: endothelium; F: ﬁbroblast; asterisk: vascular lumen; bar: 1μ.
There are uranyl acetate and lead citrate staining.
prevented by antioxidant treatment [29]. This mechanism
may be related to vacuolated and swollen mitochondria
observed in diabetic rat brain; however, it cannot be ruled
out that the oxidative stress could be a consequence of a
previous mitochondrial damage by increased intracellular
glucose or by the eﬀects of other damage inducers during
diabetes. As interesting observation, unaltered mitochondria
were often observed beside swollen or vacuolated mitochon-
dria suggesting a selective mitochondrial resistant to the
diabetic injury or a mitochondrial compensatory eﬀect byExperimental Diabetes Research 9
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Figure 10: Diverse grades of oligodendrocyte abnormalities. (a) and (b) show cytoplasm and organelle swelling and altered myelinated
axons (arrows); Bars: 1μ. There are uranyl acetate and lead citrate staining.
Figure 11: Fragmentation of neuroﬁlaments in an unmielinated
axon (arrow) in cerebral cortex; Bar: 1μ.T h e r ea r eu r a n y la c e t a t e
and lead citrate staining.
increasing their number. These mitochondrial alterations
could be accompanied by impairment mitochondrial func-
tion. In this regard, swollen hippocampal mitochondria
from 4-week STZ rats downregulate GAP-43 and MKP-
1 expressions; proteins relate to memory and cognition
[30].
Diabetic peripheral neuropathy is the most common
complication of diabetes; however, brain neuropathy has not
been well studied. In this study, several grades of myelin
alterations were observed in the diﬀerent regions of the
brain. Alteration type I could degenerate to wide myelin
disarrangement (type III). These myelin abnormalities may
be involved in a decreased propagation of nerve impulse
and contribute to the brain disorders observed in diabetes.
Several mechanisms have been suggested in myelin alter-
ations in the brain of SZT–diabetic rats, such as decreased
myelin-associated glycoprotein, autoantibodies to myelin
basic protein, and myelin damage induced by nitric oxide
[3, 31–33].
It is expected, in myelin abnormalities and demyeli-
nation in the central nervous system, the oligodendrocyte
remyelination [34]. In this regard, ultrastructural alter-
ations of oligodendrocytes observed in this study sug-
gest an impairment oligodendrocyte functions. Supporting
this, STZ-induced diabetes hindered both oligodendrocyte
and Schwann cell remyelination; hyperglycemia inhibits
Schwann cell proliferation and restricts regeneration of
Table 2: Percentages of mitochondrial alterations in diabetes.
Control Diabetes P values
Cerebrum
Cellular body
VM
a 2.1 ± 2.4 25.7 ± 9.81 P = .01
SM
b 4.73 ± 1.97 29.4 ± 8.9 P = .01
Total 6.79 ± 1.8 55.13 ± 5.5 P = .005
Neuropil
VM 2.0 ± 2.3 27.9 ± 4.11 P = .0004
SM 4.60 ± 3.3 14.65 ± 4.24 P<. 04
Total 6.6 ± 2.9 36.16 ± 15.78 P<. 04
Cerebellum
Cellular body
VM 5.13 ± 3.5 28.8 ± 2.2 P<. 006
SM 4.45 ± 1.8 20.5 ± 4.6 P<. 006
Total 9.55 ± 4.97 49.32 ± 5.79 P<. 006
Neuropil
VM 3.3 ± 2.8 34.3 ± 1.74 P<. 002
SM 1.68 ± 1.73 13.16 ± 7.66 P<. 002
Total 4.95 ± 3.6 47.42 ± 8.8 P<. 002
Hypothalamus
Cellular body
VM 3.85 ± 1.06 29.35 ± 12.31 P = .02
SM 3.83 ± 3.06 21.28 ± 5.07 P<. 005
Total 7.65 ± 4.06 50.61 ± 8.24 P<. 005
Neuropil
VM 6.03 ± 2.25 25.63 ± 8.67 P<. 04
SM 1.9 ± 0.74 9.0 ± 3.97 P<. 04
Total 7.93 ± 2.02 34.64 ± 11.84 P<. 04
aVM: vacuolated mitochondria; bSM: swollen mitochondria.
axons[35]andRAGEexpressiononoligodendrocytesduring
experimental diabetes induces abnormal RAGE signaling
with further cellular dysfunction [36]. It is possible that
similar mechanisms are acting on oligodendrocytes in
the central nervous system and may be related to the
oligodendrocyte ultrastructural changes observed in this
study.10 Experimental Diabetes Research
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Figure 12: Synaptic area in diabetes. (a) Axonal bouton (arrow) showing dispersion of synaptic vesicles; PS: Postsynaptic area. (b) Swollen
axonal boutons with dispersion of synaptic vesicles and mitochondrial swelling (arrows); Bars: 0.2μ; There are uranyl acetate and lead citrate
staining.
Table 3: Percentages of myelin alterations in diabetes.
Cerebral cortex Control Diabetes P values
Alteration type
I4 . 3 3 ± 3.10 9.56 ± 2.98; NS
II 2.17 ± 1.57 4.72 ± 3.36 NS
III 0 1.43 ± 1.2
Total 5.85 ± 6.57 15.74 ± 5.51 NS
Cerebellum
Alteration type
I6 . 1 7 ± 4.48 13.68 ± 11.5 NS
II 3.84 ± 3.37 33.12 ± 10.32 P = .001
III 1.01 ± 1.36 35.51 ± 20.28 P = .01
Total 11.02 ± 4.58 79.85 ± 17.18 P<. 0002
Hypothalamus
Alteration type
I8 . 0 6 ± 2.07 19.98 ± 5.7 P<. 0001
II 2.68 ± 2.28 28.34 ± 3.28 P<. 0001
III 0 11.51 ± 4.21
Total 10.75 ± 4.19 59.83 ± 9.64 P<. 0001
Table 4: Forced swimming test and motor activity in controls and
diabetic rats.
Parameter Control Diabetes
Struggle time (seconds) 27.36 ± 11.46 16.2 ± 6.10a
Ambulatory activity (pulses) 238.4 ± 160.5 113.25 ± 36.25a
Number of movements (pulses) 59.4 ± 23.7 35.0 ± 15.57a
aP<. 05 versus control.
Swollen axonal synaptic bouton with vacuolated and
swollen mitochondria and high dispersion of synaptic vesi-
cles was observed in the neuropil. These ultrastructural
ﬁndings suggest an altered synaptic transmission and could
contribute to abnormal synaptic plasticity and cognitive
impairments observed in experimental diabetes [37, 38].
Dispersion of synaptic vesicles could be an early alteration,
since similar ﬁndings have been reported in 9-day diabetic
STZ- rats in the presynaptic hippocampal mossy ﬁber
terminals [39]. In addition, alterations in axonal neuro-
ﬁlaments were also observed in this study. Several axons
showed fragmentation of neuroﬁlaments suggesting damage
in the axonal transportation and impairment of neuron
functions. Similarly, diabetic neuroﬁlament alterations have
been reported by others. In this regard, lack of insulin brain
stimulation induces JNK hyperphosphorylation followed by
hyperphosphorylation of tau and neuroﬁlament damage
showing as ultrastructural bunches [40]. In addition, neu-
roﬁlaments can be GLcNAcylation/phosphorylation during
diabetes leading to dysfunctional proteins [41].
As expected consequence of brain damage, necro-
sis, and/or apoptosis could take place during diabetic
encephalopathy. In this study apoptosis was found increased
in the diﬀerent regions of the brain but did not reach signiﬁ-
cant statistic values, suggesting that diabetic encephalopathy
could be related to necrosis and/or to dysfunctional dis-
orders. Hyperglycemia observed in this study could induce
cellular death by enhancing tissue acidosis [17].
Structuralandultrastructuralbrainchangeswereaccom-
paniedbydepressionindiabeticanimals.Ourresultsshowed
that diabetic animals had basal depressive behavior as shown
by decreased struggle time and ambulatory activity. These
data suggest that depression is involved in experimental
diabetes and agree with the clinical depression observed
in diabetic humans [42]. Cerebral cortex, cerebellum, and
hypothalamushavebeenshowntobeinvolved in depression.
Cerebral metabolism abnormalities have been reported in
patients with major and bipolar depression [43, 44]. Studies
based on the hypothesis that metabolism impairment might
be involved in the pathophysiology of depression, have
shown that mitochondrial complexes I, III, and IV were
inhibited only in cerebral cortex and cerebellum in chronic
stress-induced depression in rats [45]. In addition, mito-
chondrial citrate synthase used as a marker of mitochondrial
function has been reported decreased in depressed patients
[46]. Thus, the mitochondrial ultrastructural alterations
observed in cerebellum and cerebral cortex in this study
could be involved in those functional alterations. In addition
to functional impairment, cerebral cellular damage has beenExperimental Diabetes Research 11
reported in experimental depression. In this regard, chronic
stress/depression increases the vulnerability of neurons in
the rat cerebral cortex by increasing caspase-3 positive
neurons, suggesting apoptosis [47], a phenomenon observed
in this study. The potential role of cerebellum in the
pathophysiology of psychiatric disorders has also been
reported. Structural and functional cerebellar abnormalities
have been related to bipolar disorder, major depressive
disorder and other psychiatric alterations [48, 49]. Structural
and ultrastructural alterations in hypothalamus observed in
this study could be related to depressive mood in rats. In
this regard, dysregulation of the hypothalamus-pituitary-
adrenal (HPA) axis is frequently observed in human and
experimental depression [50, 51].
In conclusion, our results support previous ﬁndings and
add new information in the structural and ultrastructural
alterations in the diabetic rat brain. Although it is diﬃcult
to extrapolate our ﬁndings to the human condition, the
morphologicalalterationsobservedinthisreportmaybeone
mechanism in the pathophysiology of depressive disorders.
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